A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
The rate of cervical cancer among women living in neighborhoods with the lowest socioeconomic indices is nearly two times higher than the rate among those who live in areas with the highest indices.
A Columbia study may lead to stomach cancer screening guidelines, especially for Black and Hispanic Americans who have a greater risk of developing or dying from stomach cancer than white Americans.
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.
Columbia breast cancer patient Karin Diamond credits regular mammograms for catching her cancer early and her surgeon's use of intraoperative radiation for keeping her cancer-free.
Overall survival for breast cancer has improved by about 40% since the 1980s. Precision medicine and new screening tests may lead to even better outcomes in the future.
The 2021 edition of Velocity raised $1.1 million to support cancer research and care at Columbia University's Herbert Irving Comprehensive Cancer Center.
Despite clinical guidelines that advocate surgery as a first step, a Columbia study suggests many patients with advanced ovarian cancer should be treated with chemotherapy before surgery.